Search
for
Sort by
Research 241–270 of 1000+
- Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Liarozole—a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate
- The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model
- Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial
- 5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review
- Male pattern baldness and the risk of prostate cancer
- Finasteride-its impact on sexual function and prostate cancer
- Patients with a large prostate show a higher prevalence of androgenetic alopecia
- Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study
- Differential expression of steroid 5α-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer
- Characteristics of flutamide action on prostatic and testicular functions in the rat
- Male pattern baldness and prostate cancer risk in a population-based case–control study
- Androgenetic alopecia as an early marker of benign prostatic hyperplasia
- Ganoderma lucidum is an inhibitor of testosterone-induced prostatic hyperplasia in rats
- Dutasteride for the treatment of benign prostatic hyperplasia
- Benign Prostatic Hyperplasia: A Disorder of Androgen Metabolism in the Male
- Comparative Study of Therapeutic Effect of Dibenyline, Finasteride, and Combination Drugs for Symptomatic Benign Prostatic Hyperplasia
- Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review
- Relationship of Early-Onset Baldness to Prostate Cancer in African-American Men
- Ezetimibe Reduces Enlarged Prostate in an Animal Model of Benign Prostatic Hyperplasia
- Corn silk extract improves benign prostatic hyperplasia in experimental rat model
- Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis
- Cardiovascular effects of hormone therapy for prostate cancer
- Male Pattern Baldness in Relation to Prostate Cancer–Specific Mortality: A Prospective Analysis in the NHANES I Epidemiologic Follow-up Study
- The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor
- Role of 5 alpha-reductase inhibitors in the management of prostate cancer
- Finasteride for prostatic disease: an updated and comprehensive review
- Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception1
- Rat steroid 5α-reductase kinetic characteristics: Extreme pH-dependency of the type II isozyme in prostate and epididymis homogenates